22q11.2 Deletion Syndrome in Offspring Conceived via Assisted Reproductive Technology Versus Spontaneously
Authors:
- Jennifer BorowkaJBJennifer Borowka
- Terrence Blaine CrowleyTCTerrence Blaine Crowley
- Ashika ManiAMAshika Mani
- Victoria GuintaVGVictoria Guinta
- Daniel E. McGinnDMDaniel E. McGinn
- Bekah WangBWBekah Wang
- Audrey GreenAGAudrey Green
- Lydia RockartLRLydia Rockart
- Oanh TranOTOanh Tran
- Beverly S. EmanuelBEBeverly S. Emanuel
- Elaine H. ZackaiEZElaine H. Zackai
- Lorraine DugoffLDLorraine Dugoff
Open Access
Abstract
Background/Objectives: The majority of chromosome 22q11.2 deletions are de novo, resulting from meiotic non-allelic homologous recombination (NAHR). While 22q11.2 deletion syndrome (22q11.2DS)-associated phenotypes are well characterized, risk factors leading to NAHR are poorly understood, including the possible relationship with assisted reproductive technology (ART). Here we examined the prevalence of ART conceptions and medical comorbidities in patients with 22q11.2DS vs. spontaneously conceived (SC) patients with 22q11.2DS. Methods: Retrospective analysis, under IRB approval, of medical records on 1184 patients with laboratory-confirmed de novo chromosome 22q11.2 deletions was performed. ART conceptions included IVF with and without ICSI. Deletion size and obstetric, family, and medical histories were examined. Results: We identified 30 pregnancies conceived using ART (2.57%) compared with the U.S. general population rate of 2.3% (p-value = 0.6603). ART and SC sub-cohorts demonstrated no significant differences in deletion size or perinatal outcomes, including preterm birth, multiples, polyhydramnios, or congenital heart disease. Controlling for these factors, neonates conceived via ART were more likely to be admitted to the ICU (aOR = 6.3). Conclusions: Pregnancies conceived via ART, and later found to have 22q11.2DS, demonstrated no significant differences in prevalence or perinatal outcomes compared with the U.S. general population. Moreover, NAHR is unrelated to ART in this population. Likewise, associated phenotypic features are unrelated. These data will be reassuring to those families where ART was employed to conceive children who were later found to have 22q11.2DS.Keywords
This publication has 25 references indexed in Scilit:
- Culture conditions in the IVF laboratory: state of the ART and possible new directionsJournal of Assisted Reproduction and Genetics, 2023
- Comparison of Genetic Profiles of Neonates in Intensive Care Units Conceived With or Without Assisted Reproductive TechnologyJAMA Network Open, 2023
- Updated clinical practice recommendations for managing children with 22q11.2 deletion syndromeGenetics in Medicine, 2023
- Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndromeGenetics in Medicine, 2023
- Associations of Assisted Reproductive Technology and Twin Pregnancy With Risk of Congenital Heart DefectsJAMA Pediatrics, 2020
- Molecular genetics of 22q11.2 deletion syndromeAmerican Journal of Medical Genetics Part A, 2018
- 22q11.2 deletion syndrome: A tiny piece leading to a big pictureAmerican Journal of Medical Genetics Part A, 2018
- Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnanciesPrenatal Diagnosis, 2015
- Understanding the Role of Tbx1 as a Candidate Gene for 22q11.2 Deletion SyndromeCurrent Allergy and Asthma Reports, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009